Mitoxantrone

Mitoxantrone in Combination Chemotherapy as Treatment for Refractory Acute Leukemia

米托蒽醌为主方案治疗难治性急性白血病

Mitoxantrone , fluorouracil and leucovorin in the treatment of 41 cases with metastatic breast cancer

米托蒽醌、氟尿嘧啶与亚叶酸钙联合治疗有转移的乳腺癌41例

Study for security evaluation of Mitoxantrone Hydrochloride and Sodium Chloride Injection

盐酸米托蒽醌氯化钠注射液安全性评价

Clinical study on treating acute leukemia with combinative chemotherapy based on mitoxantrone

米托蒽醌为主联合化疗治疗急性白血病的临床研究

Objective To study the security of Mitoxantrone Hydrochloride and Sodium Chloride Injection .

目的考察盐酸米托蒽醌氯化钠注射液制剂安全性评价。

Study on the drug release in vitro of mitoxantrone starch microsphere

米托蒽醌淀粉微球的体外释药考察

Observation of clinical curative effect for acute leukemia using mitoxantrone and other chemotherapy agents

米托蒽醌联合用药治疗成人急性白血病临床观察

The peak current was proportional to the concentration of mitoxantrone .

峰电流与米托蒽醌的浓度成线性关系。

Determination of antitumour drug mitoxantrone in plasma using HPLC column switching technique

HPLC柱切换法测定抗癌药米托蒽醌血浆浓度

Clinical observation of combined treatment with mitoxantrone and cytarabine in acute leukemia

米托蒽醌联合阿糖胞苷治疗急性白血病的临床观察

Inhibiting Effect of Mitoxantrone on Cell Cycle Progression of Chinese Hamster Ovary Cells

米托蒽醌对中国仓鼠卵巢细胞周期的阻断

Clinical observation of children patients with recurrent primary refractory acute leukemia treated combination with mitoxantrone

米托蒽醌联合治疗儿童难治性复发性急性白血病的临床疗效观察

Methods Spacer was used to join insulin and mitoxantrone .

方法通过间隔基连接米托蒽醌和胰岛素；

Activity of mitoxantrone against experimental tumors in mice

米托蒽醌对动物实验肿瘤的抑制作用

Objective : To evaluate the effect and side effect of mitoxantrone combination chemotherapy for advanced breast cancer .

目的：观察以米托蒽醌为主的联合化疗治疗晚期乳腺癌的近期疗效与毒性反应。

An Observation of the Anticancer Activity of Mitoxantrone Hydrochloride Injection

盐酸米托蒽醌注射液抗癌活性观察

A study of acute toxicity of mitoxantrone

米托蒽醌的急性毒性研究

Studies on the determination of Mitoxantrone Hydrochloride Injection

盐酸米托蒽醌注射液含量测定研究

Clinical Observation of Toxicities of Mitoxantrone in Blood Malignant tumour

含米托蒽醌化疗方案治疗血液恶性肿瘤的毒副作用临床观察

Study on drug release from mitoxantrone polylactic acid extended-release nanoparticles in vitro

米托蒽醌聚乳酸缓释毫微粒冻干针剂的体外释药特性研究

Study on the mitoxantrone carboxymethyl starch microspheres for hepatic artery chemoembolization

米托蒽醌肝动脉栓塞羧甲基淀粉微球的研究

Determination of Encapsulation Rate and Encapsulation Yield of Mitoxantrone Lipid Nanospheres

米托蒽醌类脂质纳米球包封率和包封产率的测定

Effects of inducing apoptosis on HL-60 cells with Mitoxantrone

米托蒽醌对HL-60细胞的促凋亡效应

Results The maximum concentration of mitoxantrone hydrochloride injection without interfering effect was 0.25 mg / ml.

结果注射用盐酸米托蒽醌最大非干扰浓度为0.25mg/ml。

Curative effect of Mitoxantrone plus Thalidomide and Dexamethasone on treatment of multiple myeloma

米托蒽醌联合沙利度胺、地塞米松治疗多发性骨髓瘤的疗效评价

Intercalation of mitoxantrone with human tumor cellular DNA

米托蒽醌对人癌细胞DNA的嵌合效应

Mitoxantrone combined with etoposide in the treatment of refractory leukemia

米托蒽醌联合足叶乙甙为主方案治疗难治性恶性血液病的临床观察

Study on mitoxantrone albumin microspheres for liver targeting

肝靶向米托蒽醌白蛋白微球的研究

This paper reports the toxicities of mitoxantrone in treating 37 cases with blood malignant tumour .

本文应用含米托蒽醌的化疗方案治疗37例血液恶性肿瘤，观察其毒副作用。

Clinical study of intravesical reperfusion of mitoxantrone for the prevention of postoperative recurrence of bladder cancer

再灌注后这些变化迅速恢复。米托蒽醌灌注预防膀胱癌术后复发的临床研究